PrEP for Women
May 21, 2014
In May 2014, the CDC released updated guidelines for the use of PrEP in the US. These guidelines recommend that PrEP with daily, oral Truvada be considered for HIV-negative people who are at substantial risk for HIV. This includes people who:
- are in a sexual relationship with a partner living with HIV
- do not regularly use condoms and who do not know the HIV status of their sexual partner(s)
- have a high number of sexual partners
- are engaged in commercial sex work
- have had a recent bacterial sexually transmitted disease
- use injections drugs and (1) share drug equipment, or (2) were recently in a drug treatment program
There are also some reasons that PrEP is NOT recommended. These include having:
- unknown HIV status; it is important that only HIV-negative people take PrEP
- signs or symptoms of acute HIV infection
- decreased kidney function
- unknown hepatitis B status and/or vaccination status
The guidelines also suggest that providers consider PrEP for those persons living in areas or personal networks where HIV is more common (“high prevalence areas”). The guidelines provide tools to help providers identify these areas. The CDC also published a clinical providers' supplement, which includes a patient/provider checklist, counseling about using PrEP while trying to become pregnant and during pregnancy, counseling about adherence and HIV risk reduction, and information sheets for patients in English and Spanish.
It is important to note that PrEP needs to be taken daily as prescribed to maximize its effectiveness. To provide high-level protection, PrEP needs to be taken for five to seven days for anal sex and up to three weeks for vaginal sex. It needs to be used in combination with other HIV prevention strategies (i.e., condoms and safer sex and injecting practices), and is not intended to be used alone to prevent the spread of HIV, because it is not 100 percent effective.
It is also important that all those being prescribed Truvada as PrEP have a negative HIV test before starting the medication and that they get tested regularly while taking it. The CDC guidelines recommend that people be tested every three months to make sure they remain HIV-negative while taking PrEP.
Lastly, the CDC recommends that HIV-negative women who are pregnant or who are trying to become pregnant talk with their health care providers about the risks and benefits of taking Truvada for PrEP. In 2014, the US Public Health Service released clinical practice guidelines suggesting that health care providers now discuss PrEP as one of several options for protecting HIV-negative partners in serodifferent, or serodiscordant couples when they are interested in getting pregnant.
Both Viread and Truvada, when used as PrEP for HIV-negative women, appear safe in early pregnancy. Information from the Partners PrEP study conducted among serodiscordant heterosexual couples in Africa showed that babies conceived when the mother was taking either Viread or Truvada did not experience negative effects on birth outcomes or infant growth. Women living with HIV have been taking these HIV drugs safely during pregnancy for many years to prevent their babies from getting HIV.
The World Health Organization (WHO) has issued guidance for heterosexually active women and men. It recommends that, in countries where HIV is spread in couples in which one partner is living with HIV, tenofovir (Viread) or Truvada be considered as possible additional prevention choices for the HIV-negative partner. Further recommendations for oral PrEP are expected from the WHO in 2015.
While many HIV advocates believe that Truvada as PrEP is a good addition to the prevention toolbox, some people disagree. Just as adherence is a factor for people living with HIV, there are concerns that HIV-negative people may not adhere to the drugs and therefore PrEP will not be effective.
There are also concerns that HIV-negative people will use PrEP in place of condoms or other safer sex measures. Although PrEP is designed to be used in addition to condoms or other safer sex measures or safer injection practices, one of the benefits of PrEP is that it can be taken without the agreement or knowledge of one's sex partner. Since condoms, when used properly, are more effective and less expensive than PrEP in preventing HIV, some believe that the approval of Truvada as PrEP may have a negative effect on these prevention efforts, and lead to additional HIV infections. To date, research has not shown that the use of PrEP has led to a reduction in the use of condoms or other safer sex methods.
Some women asked about the possibility of using PrEP have expressed concerns about possible side effects. The studies of Truvada as PrEP have found that the most common side effects were nausea and vomiting. These side effects often occur among people taking a new HIV drug and often go away after a few days to weeks.
While no serious side effects were found during the studies, Truvada can occasionally cause serious effects, including kidney problems, liver problems, lactic acidosis, lipodystrophy, and bone problems. Recent studies show that a small, but important decrease in bone mineral density (a measure of bone strength) can been seen in men and transgender women taking Truvada as PrEP. Given that women are more susceptible to bone loss and fracture than men, it is important that we understand the potential long-term effects of Truvada, especially for women who are HIV-negative.
In addition, if HIV-negative people taking PrEP become HIV+, do not know it, and continue to take Truvada, there is the possibility that their HIV will become resistant to Truvada and other similar HIV drugs. This not only can reduce treatment options for the individuals who become HIV+, but also can have serious consequences for public health, as Truvada-resistant HIV could then be spread to others.
Given the results of the FemPrEP and VOICE studies, it is clear that there is more to learn about the effectiveness of Truvada as PrEP in women. Some people believe we have enough knowledge to go ahead and begin using PrEP now, while others think we should wait until we have more proof that it is effective for women.
While we now have evidence that PrEP works in preventing HIV if the drugs are taken as prescribed, much more work needs to be done before PrEP becomes widely used and accepted. This includes improving health care systems so that people can access and afford PrEP and making HIV testing more widely available, since only people who know they are HIV-negative can use PrEP safely. If people use PrEP when they are already living with HIV, they are much more likely to develop drug-resistant HIV, which they may then pass on to others. Having drug-resistant virus can also make it harder to treat HIV infection (see The Well Project's article on Resistance).
PrEP is a promising tool that women can use to prevent HIV infection without their partners' cooperation. However, many questions remain. How will taking PrEP affect pregnancy and breastfeeding? How will women get HIV testing, especially if their partners refuse to get tested? Will they be able to get PrEP if they do not know their partners' HIV status? Will a man be more likely to refuse to use a condom if he knows his partner is taking PrEP? Will women be able to keep the PrEP drugs given to them? Some women worry that the drugs given to them might be taken away and given to another family member who is viewed as "needing them more." These and other questions are currently being explored in both research and advocacy efforts in the US and worldwide.
If you think PrEP may be a good option for you, here are a few questions you can talk over with your health care provider:
- How often—and for how long (i.e., days, weeks)—do I need to take PrEP if I am trying to protect myself from HIV? What happens if I miss a dose or several doses?
- What are Truvada's likely side effects and how will I manage them?
- How often will I need to be tested for HIV?
- How much will the drug cost me? Will it be covered by my insurance? Will the HIV tests also be covered by my insurance?
- Do any of my current medical conditions make Truvada a less-good choice for my health overall?
- Do any of my other prescription medications, over-the-counter drugs, street drugs, herbs, vitamins, or supplements have interactions with Truvada?
- What should I do if I become pregnant while on PrEP?
There is also a good checklist available at How to Talk to Your Doctor about PrEP. You may also want to discuss the pros and cons of taking Truvada as PrEP compared to using condoms or other safer sex techniques to reduce the risk of getting HIV. While PrEP is designed to be used in combination with condoms or other safer sex measures, women who cannot or do not use condoms may want to use PrEP in place of condoms. It is important to understand the overall risks and benefits of using PrEP to reduce one's HIV risk, as well as to consider methods of protection from other sexually transmitted diseases.
Adapted and updated from "PrEP: What Does It Mean for Women? with permission from Global Campaign for Microbicides and AIDS United.
|More on HIV Medications for HIV Prevention|
Caring for a Woman's Body: What Every HIV-Positive Woman Should Know About the Care and Prevention of GYN Problems
No comments have been made.
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
Copyright © 2007-2014 Remedy Health Media, LLC. All rights reserved.